NCT03966573

Brief Summary

This study evaluates function, quality of life and development of hip- and knee osteoarthritis minimum 15 years after unilateral femoral lengthening on people with idiopathic or post-traumatic anisomelia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 6, 2019

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

March 19, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 29, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2019

Completed
Last Updated

February 26, 2021

Status Verified

February 1, 2021

Enrollment Period

7 months

First QC Date

March 19, 2019

Last Update Submit

February 23, 2021

Conditions

Outcome Measures

Primary Outcomes (8)

  • hip or knee osteoarthritis

    Radiographic imaging. Kellgren \& Lawrence classification and joint space width will be measured

    One day

  • Lower extremity strength

    30 seconds sit to stand test, measuring strength in lower extremities

    one day

  • Lower extremity function

    Single leg hop tests

    one day

  • Aerob capasity

    Stair test, 18 steps up and down three times

    one day

  • measure of health related quality of life with EQ-5D-5L

    participants report the extent of problems they have with endpoints 1-5, where 1 is no problems and 5 is not able to in the five dimensions mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The questionnaire also contains a vertical analogue scale with the labelled endpoints 0-100 where 0 is the worst imaginable health state and 100 the best imaginable health state, giving a valuation of the participants own health state that can be used as a quantitative measure of health outcome based on the patients' own judgement

    one day

  • measure of function and pain with Knee Osteoarthritis Outcome Score (KOOS)

    The participant answer questions regarding pain, function, stiffness and quality of life regarding knee pain. Endpoints 0 - 4, where 0 indicate no problems and 4 indicate extreme problems

    one day

  • measuring physical activity level with International Physical Activity Questionnaire (IPAQ)

    Participants answer the amount of time being in vigorous activity, moderate activity, walking and sitting during the last 7 days. Answers are given in number of days in each of the activity categories, and time in hours and minutes on a regular day the actual week

    one day

  • Active range of motion

    Hand held goniometric measurement of active range of motion in hip and knee bilaterally

    one day

Study Arms (1)

Evaluating function, Radiographic imaging, Forms

OTHER

* Tests for lower extremity function * Evaluating arthritis of hip and knee, leg length discrepancy and axis deviation radiographically * Evaluating quality of life, function and pain by forms

Radiation: Radiographic imagingOther: Evaluating functionOther: Forms

Interventions

Evaluating arthritis in knee and hip bilaterally. Evaluating axis deficiancy and leg length discrepancy.

Also known as: Knee front, knee side, lower extremity axis front, lower extremity axis side, pelvis front
Evaluating function, Radiographic imaging, Forms

Test function and physical capasity

Also known as: 30 seconds sit to stand, single leg hop test, stair test, goniometric ROM measurement hip and knee
Evaluating function, Radiographic imaging, Forms
FormsOTHER

Forms for evaluating quality of life, pain, function

Also known as: EQ-5D-5L, KOOS - knee osteoarthritis outcome score, IPAQ - international physical activity questionnaire
Evaluating function, Radiographic imaging, Forms

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with idiopathic or post traumatic leg length discrepancy who are lengthened with the callutasis method minimum 15 years ago

You may not qualify if:

  • Patients that are lenghtened with innate pathology resulting in shortening of the limb, angle deviation and less musculature, for example congenital femoral deficiency or fibula hemimelia.
  • Patients with acquired leg length discrepancy who have had infection in knee or hip joint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0372, Norway

Location

Related Publications (1)

  • Bjorge PA, Tveter AT, Steen H, Gunderson R, Horn J. Femoral lengthening might impair physical function and lead to structural changes in adjacent joints: 10 patients with 27 to 34 years' follow-up. Acta Orthop. 2021 Jun;92(3):329-334. doi: 10.1080/17453674.2020.1866864. Epub 2021 Jan 7.

MeSH Terms

Conditions

Leg Length InequalityOsteoarthritis, KneeOsteoarthritis, Hip

Interventions

Phantoms, Imaging

Condition Hierarchy (Ancestors)

Bone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsOsteoarthritisArthritisJoint DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

March 19, 2019

First Posted

May 29, 2019

Study Start

March 6, 2019

Primary Completion

October 11, 2019

Study Completion

October 11, 2019

Last Updated

February 26, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will share

IDP that underlie results in a publication

Time Frame
Data will become avaliable within 6 months of study completion
Access Criteria
Shared in an open access publication

Locations